RxDoctor Payments Data

Jacob Smithey, MD

Orthopaedic Surgery · Tupelo, MSNPI 1053871913

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (40.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Smith+Nephew at 52.6% of the total. 2025 is the largest year on record at $5,691, 3.5 times the $1,620 reported in 2019.

$16,640in general payments, 2019–2025

Across 65 payments — averaging $256.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$9K
  • Medacta USA, Inc.$2K
  • Medical Device Business Services, Inc.$2K
  • ALON Medical Technology$1K
  • Stryker$1K
  • Orthalign Inc$930
  • plus $1K from 9 others

What the payments were for

  • Grants$6,66740%
  • Travel & lodging$5,14731%
  • Food & beverage$3,62722%
  • Education$1,2007%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,640 in reported general payments places this provider in the 75th percentile of 170 orthopaedic surgery providers in Mississippi.

See all orthopaedic surgery providers in Mississippi

Medicare billing

Part B allowed, 2024
$14,572
Medicare patients
83
Services billed
83

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron Hcl13$60

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →